T2 lesions and rate of progression of disability in multiple sclerosis

被引:25
|
作者
Mostert, J. P. [1 ,2 ]
Koch, M. W. [1 ]
Steen, C. [1 ]
Heersema, D. J. [1 ]
de Groot, J. C. [3 ]
De Keyser, J. [1 ,4 ]
机构
[1] Univ Groningen, Dept Neurol, Univ Med Ctr Groningen, NL-9713 GZ Groningen, Netherlands
[2] Rijnstate Hosp, Dept Neurol, Arnhem, Netherlands
[3] Univ Groningen, Dept Radiol, Univ Med Ctr Groningen, NL-9713 GZ Groningen, Netherlands
[4] Free Univ Brussels, Univ Hosp Brussels, Dept Neurol, Brussels, Belgium
关键词
disease progression; MRI; multiple sclerosis; prognosis; AXONAL LOSS; INTERFERON BETA-1B; PREDICTIVE-VALUE; MRI; DISEASE; TRIAL; ONSET; PHASE; MS;
D O I
10.1111/j.1468-1331.2010.03093.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and purpose: To assess the predictive value of T2 lesions on the rate of progression of disability in multiple sclerosis (MS). Methods: We reanalyzed T2 lesion number and load on brain MRI scans, performed before 1997, of 186 MS patients, who were clinically followed. There were 90 patients with progressive MS (35 secondary progressive and 55 primary progressive), and 96 with relapsing remitting MS. The rate of progression of disability was measured by time to sustained progression of disability (defined as an increase in >= 1 point when the Expanded Disability Status Scale (EDSS) was 5.5 or less and an increase in EDSS of >= 0.5 point when the EDSS was 6.0 or higher), and by the Multiple Sclerosis Severity Score (MSSS). Results: During follow-up (median 15 years, IQR 12-17 years), 94% of the patients with progressive MS and 50% of the patients with relapsing remitting MS had progression of disability. Higher T2 lesion number and load were modestly associated with a higher rate of disease progression on the MSSS and a shorter time to progression of disability in relapsing remitting MS, but not in progressive MS. Conclusions: Our findings indicate that the amount of T2 lesions has a small predictive value for progression of disability in relapsing remitting MS, but has no influence on the rate of progression in progressive MS.
引用
收藏
页码:1471 / 1475
页数:5
相关论文
共 50 条
  • [31] T2 relaxation time histograms in multiple sclerosis
    Grenier, D
    Pelletier, D
    Normandeau, M
    Newitt, D
    Nelson, S
    Goodkin, DE
    Majumdar, S
    MAGNETIC RESONANCE IMAGING, 2002, 20 (10) : 733 - 741
  • [32] Cortical and subcortical T2 shortening in multiple sclerosis
    Russo, C
    Smoker, WRK
    Kubal, W
    AMERICAN JOURNAL OF NEURORADIOLOGY, 1997, 18 (01) : 124 - 126
  • [33] Accelerated Simultaneous T2 and T2* Mapping of Multiple Sclerosis Lesions Using Compressed Sensing Reconstruction of Radial RARE-EPI MRI
    Herrmann, Carl J. J.
    Starke, Ludger
    Millward, Jason M.
    Kuchling, Joseph
    Paul, Friedemann
    Niendorf, Thoralf
    TOMOGRAPHY, 2023, 9 (01) : 299 - 314
  • [34] Serum neurofilament light chain is more strongly associated with T2 lesion volume than with number of T2 lesions in patients with multiple sclerosis
    Wenger, Katharina J.
    Hoelter, Maya C.
    Yalachkov, Yavor
    Schaefer, Jan Hendrik
    Oezkan, Dilek
    Steffen, Falk
    Bittner, Stefan
    Hattingen, Elke
    Foerch, Christian
    Schaller-Paule, Martin A.
    EUROPEAN JOURNAL OF RADIOLOGY, 2023, 166
  • [35] Heterogeneity of Multiple Sclerosis White Matter Lesions Detected With T2*-Weighted Imaging at 7.0 Tesla
    Yao, Bing
    Ikonomidou, Vasiliki N.
    Cantor, Fredric K.
    Ohayon, Joan M.
    Duyn, Jeff
    Bagnato, Francesca
    JOURNAL OF NEUROIMAGING, 2015, 25 (05) : 799 - 806
  • [36] Multiple Sclerosis T2 Lesions Which Disappear May Still Show Persistent Tissue Injury
    Qian, Peiqing
    Lancia, Samantha
    Xu, Junqian
    Huang, Jeffrey H.
    Cross, Anne H.
    Wolansky, Leo J.
    Cook, Stuart
    Cadavid, Diego
    Naismith, Robert T.
    NEUROLOGY, 2011, 76 (09) : A324 - A324
  • [37] Confirmed disability progression as a marker of permanent disability in multiple sclerosis
    Sharmin, S.
    Malpas, C.
    Lechner-Scott, J.
    Slee, M.
    McCombe, P.
    Vucic, S.
    Butler, E.
    Hodgkinson, S.
    Barnett, M.
    Skibina, O.
    van der Walt, A.
    Buzzard, K.
    Shaw, C.
    Kermode, A.
    Taylor, B.
    Shuey, N.
    Macdonell, R.
    Butzkueven, H.
    Kalincik, T.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 : 8 - 8
  • [38] Relapses and progression of disability in multiple sclerosis.
    Confavreux, C
    Vukusic, S
    Moreau, T
    Adeleine, P
    NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (20): : 1430 - 1438
  • [39] Confirmed disability progression as a marker of permanent disability in multiple sclerosis
    Sharmin, Sifat
    Bovis, Francesca
    Malpas, Charles
    Horakova, Dana
    Havrdova, Eva Kubala
    Izquierdo, Guillermo
    Eichau, Sara
    Trojano, Maria
    Prat, Alexandre
    Girard, Marc
    Duquette, Pierre
    Onofrj, Marco
    Lugaresi, Alessandra
    Grand'Maison, Francois
    Grammond, Pierre
    Sola, Patrizia
    Ferraro, Diana
    Terzi, Murat
    Gerlach, Oliver
    Alroughani, Raed
    Boz, Cavit
    Shaygannejad, Vahid
    van Pesch, Vincent
    Cartechini, Elisabetta
    Kappos, Ludwig
    Lechner-Scott, Jeannette
    Bergamaschi, Roberto
    Turkoglu, Recai
    Solaro, Claudio
    Iuliano, Gerardo
    Granella, Franco
    Van Wijmeersch, Bart
    Spitaleri, Daniele
    Slee, Mark
    McCombe, Pamela
    Prevost, Julie
    Ampapa, Radek
    Ozakbas, Serkan
    Sanchez-Menoyo, Jose Luis
    Soysal, Aysun
    Vucic, Steve
    Petersen, Thor
    de Gans, Koen
    Butler, Ernest
    Hodgkinson, Suzanne
    Sidhom, Youssef
    Gouider, Riadh
    Cristiano, Edgardo
    Castillo-Trivino, Tamara
    Saladino, Maria Laura
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 (08) : 2321 - 2334
  • [40] Impact of maternity in the progression of disability in multiple sclerosis
    Mendibe, Mar
    Ibanez, Berta
    Barcena, Jose
    Antigueedad, Alfredo
    MULTIPLE SCLEROSIS, 2008, 14 : S58 - S58